Abstract:Research on biocompatible metal-organic frameworks (MOFs) has recently attracted much attention from researchers as drug delivery systems. In this study, for the first time, Cu MOFs grown on graphene oxide capped with magnetic hydroxyapatite (MOF Cu@GO/HAp-SiO 2 -Fe 3 O 4 ), and then the surface of the resulting nanocomposites was modified with the l -lysine amino acid (Lys-MOF Cu@GO/HAp-SiO 2 -Fe 3 O 4 ) to prepare a controlled and pH-sensitive nanocomposite for targeted delivery of doxorubicin (DOX) to MDA-MB-231 breast cancer cells and MCF-10A normal cells. Different techniques confirmed the successful preparation of the designed nanocomposites. The values of encapsulation efficiencies (EE%) for MOF Cu@GO/HAp-SiO 2 -Fe 3 O 4 and Lys-MOF Cu@GO/HAp-SiO 2 -Fe 3 O 4 was found to be 79.3 % and 96.5 %, respectively. The in vitro DOX release results showed that the Lys-MOF Cu@GO/HAp-SiO 2 -Fe 3 O 4 has a more controlled release than that of MOF Cu@GO/HAp-SiO 2 -Fe 3 O 4 due to the slow diffusion of the drug through the Lys shell. In addition, both nanocomposites showed a pH-response release behavior. The release mechanism of DOX by the designed nanocomposites also revealed that the Korsmeyer-Peppas model is the best model to describe the release of the drug. Furthermore, in vitro cytotoxicity investigation confirmed that the prepared MOF Cu@GO/HAp-SiO 2 -Fe 3 O 4 and Lys-MOF Cu@GO/HAp-SiO 2 -Fe 3 O 4 nanocomposite had good biocompatibility against MDA-MB-231 and MCF-10A cells. Whereas, DOX-MOF Cu@GO/HAp-SiO 2 -Fe 3 O 4 and DOX-Lys-MOF Cu@GO/HAp-SiO 2 -Fe 3 O 4 against MDA-MB-231 cells increased the cytotoxicity as a result of the targeting and controlled delivery of the DOX to the cancer cells. The in vitro antioxidant activity and hemolysis experiments revealed that the designed Lys-MOF Cu@GO/HAp-SiO 2 -Fe 3 O 4 have excellent antioxidant activity and good haemocompatibility, respectively, as a suitable nanocomposites for drug applications. Therefore, it is suggested that the prepared nanocomposites can be good for biological applications.

Precise construction of hyaluronic acid (HA)-coated drug-loaded iron oxide metal–organic frameworks: Investigation of cell death mechanism in neuroblastoma carcinoma cells

MOF × Biopolymer: Collaborative Combination of Metal–Organic Framework and Biopolymer for Advanced Anticancer Therapy

Hyaluronic Acid-Protein Conjugate Modified Iron-Based MOFs (MIL-101 (Fe)) for Efficient Therapy of Neuroblastoma: Molecular Simulation, Stability and Toxicity Studies

Post-Synthetic Modification Nanoscale Metal-Organic Frameworks for Targeted Drug Delivery in Cancer Cells

Therapeutic Application of Metal–Organic Frameworks Composed of Copper, Cobalt, and Zinc: Their Anticancer Activity and Mechanism

Iron oxide nanoparticle encapsulated; folic acid tethered dual metal organic framework-based nanocomposite for MRI and selective targeting of folate receptor expressing breast cancer cells

Iron−Based Metal–Organic Frameworks as Multiple Cascade Synergistic Therapeutic Effect Nano−Drug Delivery Systems for Effective Tumor Elimination

Folic Acid Functionalized Zirconium-Based Metal-Organic Frameworks as Drug Carriers for Active Tumor-Targeted Drug Delivery.

Environment Responsive Metal–Organic Frameworks as Drug Delivery System for Tumor Therapy

Coupling metal organic frameworks with molybdenum disulfide nanoflakes for targeted cancer theranostics

Incorporating mannose-functionalized hydroxyapatite/metal-organic framework into the hyaluronic acid hydrogel film: A potential dual-targeted oral anticancer delivery system

Hierarchical superparamagnetic metal–organic framework nanovectors as anti-inflammatory nanomedicines

Preparation of nanoscale hafnium-containing metal-organic frameworks for X-ray-promoted chemodynamic synergistic therapy

Exosome-Coated Metal-Organic Framework Nanoparticles: An Efficient Drug Delivery Platform

Hyaluronic acid-covered ferric ion-rich nanobullets with high zoledronic acid payload for breast tumor-targeted chemo/chemodynamic therapy

Nanoscale Iron-Based Metal-Organic Frameworks: Incorporation of Functionalized Drugs and Degradation in Biological Media

Acid‐Degradable Hydrogen‐Generating Metal‐Organic Framework for Overcoming Cancer Resistance/Metastasis and Off‐Target Side Effects

Fabrication of a hyaluronic acid conjugated metal organic framework for targeted drug delivery and magnetic resonance imaging

Synthesis and biological evaluation of fluorescent hyaluronic acid modified amorphous calcium phosphate drug carriers for tumor-targeting

A l-lysine-coated graphene oxide/magnetic hydroxyapatite/cubic metal-organic frameworks for targeted and pH-controlled release of doxorubicin to cancer cells

Folic Acid and Ferritin Functionalized Reduced Iron-based Metal-Organic Frameworks for Anticancer Therapy